Health Equity, Care Models, and Predictive Tools in Hepatology
Nov
2026
Description
This session addresses disparities and structural barriers in liver disease care, along with predictive/ML-based tools and novel care delivery models (telehealth, quality measures) to improve outcomes.
Presentations
5:00 PM
- 5:15 PM
Convention Center - Bluebird Ballroom 3DEF
Sociodemographic and Structural Barriers Among Individuals with Hepatitis B in the US: Analysis of the All of Us Database
Xiaohan Ying, MD | Abstract Presenter
5:15 PM
- 5:30 PM
Convention Center - Bluebird Ballroom 3DEF
Telehealth vs In-Person Early Palliative Care for Patients with Cirrhosis: Results from the PAL-LIVER Multi-Center Trial
Manisha Verma, MD, MPH | Abstract Presenter
5:30 PM
- 5:45 PM
Convention Center - Bluebird Ballroom 3DEF
HEPATOCELLULAR CARCINOMA IN INCARCERATED INDIVIDUALS: PREVALENCE, RISK FACTORS, AND TRENDS IN A LARGE U.S. CORRECTIONAL COHORT, 2015–2023
Mahnur Haider, MD | Abstract Presenter
5:45 PM
- 6:00 PM
Convention Center - Bluebird Ballroom 3DEF
Liver Transplant Quality Measures Affect Health Outcomes: A Multicenter Analysis of the Consortium for the Holistic Assessment of Risk in Transplant
Jacqueline B Henson, MD | Abstract Presenter
6:00 PM
- 6:15 PM
Convention Center - Bluebird Ballroom 3DEF
Machine Learning-Based Phenotyping of Cryptogenic Hepatocellular Injury in the US Adult Population
Kartik Dapke, MD | Abstract Presenter
6:15 PM
- 6:30 PM
Convention Center - Bluebird Ballroom 3DEF
Sequential Algorithms Using FIB-4, Followed by VCTE or ELF to Detect Advanced Fibrosis: Validation of Risk Stratification Strategy in the United States (U.S.) Primary Care Setting
Zobair M Younossi, MD, MPH, FAASLD | Abstract Presenter
